The goal of this randomized control trial is to compare different doses of Misoprostol (25
mcg vs 50 mcg) in induction of labor (IOL) in morbidly obese patients with BMI >40. It is
known that morbid obesity is a risk factor for failed IOL and ultimately cesarean delivery
(CD.) If the rates of vaginal delivery in this population can improve, then surgical
morbidity can be reduced in these patients.